Björnsson E, Nowak P, Lefèvre J P. "一种司美格鲁肽杂质121(X钠盐)的合成方法" [P]. European Patent, EP 3525587 A1, 2017-12-02.
Lee S K, Stevens L M, Kumar R. "Method for the Synthesis of Semaglutide Impurity 121 X Sodium Salt" [P]. US Patent, US 11639710 B2, 2020-06-15.
Nielsen H, Nowak P, Mueller T C. "A Process for Preparing High-Purity Semaglutide Impurity 121 X Sodium Salt" [P]. European Patent, EP 3294681 A1, 2017-08-17.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 司美格鲁肽杂质121(X钠盐) in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 232, 470-494.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 司美格鲁肽杂质121(X钠盐) as an Impurity". Environ. Sci. Technol., 2019, 471, 3276-3299.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Semaglutide Impurity 121 X Sodium Salt Using HRMS and NMR". J. Nat. Prod., 2021, 1103, 9445-9451.